Johnson & Johnson to buy Israel-headquartered V-Wave Ltd. for USD600m up front
A big move in the healthcare sector took place this week as U.S. healthcare giant Johnson & Johnson (J&J) announced plans to buy V-Wave, a move aimed at enhancing its medical device portfolio.
Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for an upfront payment of USD600 million, subject to customary adjustments, with the potential for additional regulatory and commercial milestone payments up to approximately USD1.1 billion. V-Wave will join Johnson & Johnson as part of Johnson & Johnson MedTech.
Established in 2009, V-Wave is a privately held medical device company in Israel with offices in California. It is focused on developing innovative treatment options for people living with heart failure and cardiovascular disease. The planned acquisition of V-Wave will extend Johnson & Johnson MedTech’s position as an innovation leader in addressing cardiovascular disease.
